Clinical Trial Update: Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With Trabectedin [Phase 3]

View source ↗

Summary

A Phase 3 trial studying trabectedin for leiomyosarcoma, liposarcoma, and synovial sarcoma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Liposarcoma
• Synovial Sarcoma

Drugs mentioned

• Trabectedin (trabectedin)

Snippet

Sponsor: Italian Sarcoma Group | Conditions: Leiomyosarcoma, Liposarcoma | Phase 3 | Status: WITHDRAWN